The House and Senate were both in session this week. The House Ways & Means Health Subcommittee met to discuss policies inhibiting innovation and patient access, and the House Energy & Commerce Health Subcommittee held a...more
5/12/2023
/ Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
DEA ,
Deadlines ,
GAO ,
Healthcare ,
HELP ,
Legislative Agendas ,
Patient Access ,
Pharmaceutical Industry ,
Prescription Drugs ,
Public Health Emergency
Congress was in session, and it was a busy healthcare week at the committee level, with six hearings focused specifically on health issues. On the House floor, Republicans passed the Limit, Save, Grow Act—a bill that raises...more
5/2/2023
/ Abortion ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
DACA ,
Department of Health and Human Services (HHS) ,
Enforcement Actions ,
Federal Funding ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
HELP ,
Hospitals ,
Medicaid ,
New Legislation ,
Pharmaceutical Industry ,
Prescription Drugs ,
Price Transparency ,
Proposed Legislation ,
Proposed Rules ,
Right of Access
Lots of Healthcare Activity in Congress -
Activity in Congress focusing on healthcare issues has increased over the last few weeks and is not slowing down anytime soon. This week, the Senate Health, Education, Labor, and...more
5/1/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Coronavirus/COVID-19 ,
Drug Pricing ,
Health Care Providers ,
Healthcare ,
HELP ,
Medicaid ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Proposed Legislation ,
Proposed Rules ,
State Medicaid Programs ,
Transparency